Skip to main content
Top
Published in:

17-07-2024 | IM - CASE RECORD

Should I stay or should I go? A case of central line-associated bloodstream infection (CLABSI) differential diagnosis

Authors: Matteo Maria Masseroli, Maria Calloni, Diocleziano Menicatti, Antonella Foschi, Antonio Gidaro

Published in: Internal and Emergency Medicine | Issue 1/2025

Login to get access

Excerpt

A 56-year-old woman referred to our hospital because of skin ulceration and bleeding in the left breast area. An abscess was diagnosed and treated with antibiotic therapy and drainage. During hospitalization, a total body CT scan was performed, showing breast cancer with axillary lymph node metastases. The fine-needle aspiration of the lymph node showed an ER:0, PgR:0, Ki-67:55%, c-erbB-2:0 profile. The patient was dismissed, and a carboplatin–paclitaxel therapy once a week was started in a day hospital regimen. To perform therapy, a peripherally inserted central catheter (PICC) was positioned with maximal barrier precautions, following hospital protocol; trained nurses managed PICC during infusions and blood sampling. Home care nurses performed the breast lesion’s dressings on alternate days, following the scheme defined by a wound care expert. Six chemotherapy cycles were carried out without complications. …
Literature
1.
go back to reference Chaves F et al (2018) Diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). Med Intensive (Engl Ed) 42(1):5–36. https://doi.org/10.1016/j.medin.2017.09.012CrossRef Chaves F et al (2018) Diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). Med Intensive (Engl Ed) 42(1):5–36. https://​doi.​org/​10.​1016/​j.​medin.​2017.​09.​012CrossRef
2.
go back to reference Pittiruti M, Scopettuolo G (2021) The GAVeCeLT manual of Picc and Midline: Indications, insertion, management. Edra, Milano Pittiruti M, Scopettuolo G (2021) The GAVeCeLT manual of Picc and Midline: Indications, insertion, management. Edra, Milano
3.
go back to reference Baang JH, Inagaki K, Nagel J, Ramani K, Stillwell TL, Mack M, Wesorick D, Mack M, Wesorick D, Proudlock A (2023) Inpatient diagnosis and treatment of catheter-related bloodstream infection [Internet]. Michigan Medicine University of Michigan, Ann Arbor Baang JH, Inagaki K, Nagel J, Ramani K, Stillwell TL, Mack M, Wesorick D, Mack M, Wesorick D, Proudlock A (2023) Inpatient diagnosis and treatment of catheter-related bloodstream infection [Internet]. Michigan Medicine University of Michigan, Ann Arbor
Metadata
Title
Should I stay or should I go? A case of central line-associated bloodstream infection (CLABSI) differential diagnosis
Authors
Matteo Maria Masseroli
Maria Calloni
Diocleziano Menicatti
Antonella Foschi
Antonio Gidaro
Publication date
17-07-2024
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 1/2025
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-024-03707-3

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar